We demonstrated that Dex could promote the migration of breast cancer cells through SGK1-CTGF signaling, and that ablation of SGK1 or CTGF reduced metastatic outgrowth and prolonged survival in mouse models. Here, SGK1 is linked to breast carcinoma.